Verve Therapeutics shares owned by Nikko Asset Management Americas
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Nikko Asset Management Americas
from 13F filings
Historical chart of Nikko Asset Management Americas investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Nikko Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Verve Therapeutics by Nikko Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $33M | 2.4M | 13.90 |
2023-09-30 | $28M | 2.1M | 13.24 |
2023-06-30 | $41M | 2.2M | 18.73 |
2023-03-31 | $22M | 1.6M | 14.00 |
2022-12-31 | $24M | 1.2M | 19.35 |
2022-09-30 | $24M | 776k | 31.45 |
2022-06-30 | $1.5M | 115k | 12.89 |
2022-03-31 | $1.3M | 66k | 20.00 |
2021-12-31 | $2.3M | 71k | 32.05 |
2021-09-30 | $3.6M | 78k | 46.00 |
More positions owned by Nikko Asset Management Americas
View all positions for Nikko Asset Management Americas